Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+
March 31, 2020 | Startland News Staff
A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.
The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.
“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”
Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.
Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.
The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.
The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.
Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.
Click here to learn more about these peripheral vascular solutions.
“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”
Featured Business

2020 Startups to Watch
stats here
Related Posts on Startland News
Techstars to launch new accelerator program in Kansas City
Accelerator guru group Techstars announced Wednesday that it’s launching a new program in Kansas City after leading the Sprint Accelerator for three years with Sprint. Lesa Mitchell, a former vice president of innovation and networks for the Ewing Marion Kauffman Foundation, will serve as the managing director of the Kansas City accelerator. “We’re excited to…
Kauffman Fellows hosting hundreds of global VCs in Kansas City homecoming
More than 200 investors and entrepreneurs from around the globe will soon converge in Kansas City as part of one of the most highly-esteemed venture capital organizations in the world. Now in its 21st year, the Kauffman Fellows program will reunite top-tier investors that hail from five continents for a reunion summit on Oct. 24…
KCRise Fund makes first area investments in SpiderOak, Innara Health
Only a few weeks after closing on its first $10 million, the KCRise Fund announced Wednesday that it has invested in its first Kansas City-area companies. Launched in February in conjunction with the KC Rising economic initiative, the KCRise Fund is joining ongoing investment rounds in SpiderOak and Innara Health. The fund, led by Darcy…
Magic Johnson, David Stern headline $5M round in ShotTracker
A sojourn to the City of Angels has taken on magical meaning for ShotTracker. The Merriam-based firm announced Wednesday that basketball legend Earvin “Magic” Johnson and former NBA Commissioner David Stern are among a group of investors that have injected $5 million into its coffers. The duo of high-profile investors will help accelerate the wearable…


